Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 3Completed 2Unknown 1Terminated 1Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Pancreatic Neoplasms 100Carcinoma, Non-Small-Cell Lung 48Neoplasms 34Urinary Bladder Neoplasms 25Lung Neoplasms 25Cholangiocarcinoma 23Breast Neoplasms 22Neoplasm Metastasis 21Ovarian Neoplasms 18Lymphoma, Non-Hodgkin 13Lymphoma 13Recurrence 12Lymphoma, Large B-Cell, Diffuse 11Biliary Tract Neoplasms 11Sarcoma 10Carcinoma, Transitional Cell 9Hodgkin Disease 8Gallbladder Neoplasms 8Fallopian Tube Neoplasms 8Adenocarcinoma 8Bile Duct Neoplasms 7Colorectal Neoplasms 6Triple Negative Breast Neoplasms 5Lymphoma, Follicular 5Liver Neoplasms 5Head and Neck Neoplasms 5Carcinoma, Renal Cell 5Adenocarcinoma of Lung 5Uterine Cervical Neoplasms 4Small Cell Lung Carcinoma 4

Interventions

Injections 3pembrolizumab 2olaparib 2atezolizumab 2Leucovorin 2Irinotecan 2ulixertinib 1toripalimab 1tipifarnib 1sotorasib 1serabelisib 1mirdametinib 1famitinib 1camrelizumab 1adagrasib 1Taxes 1Ramucirumab 1Radiation 1Paclitaxel 1IFL protocol 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Fluorouracil 1Docetaxel 1Bevacizumab 1BID protein, human 1Appointments and Schedules 1Albumin-Bound Paclitaxel 1APG-1387 15-fluorouridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Advanced Solid Tumor × Gemcitabine × Clear all
NCT04761601 2024-03-13

First in Human Study of UCT-01-097 in Participants With Advanced Solid Tumors

1200 Pharma, LLC

Phase 1 Terminated
32 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡